6 completed, 1 terminated, 1 unknown, 1 withdrawn. 3 Phase 2, 2 Phase 1, 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Unknown 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Terminated 1 |
Follow Reserpine: new trials by email Literature Review of Reserpine trials Research Report on Reserpine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy Rehabilitation therapy, Intermittent Oro-esophageal Tube Feeding, Nasogastric tube feeding - Traumatic Brain Injury | Not applicable | Terminated | Zeng Changhao | 104 | 2022-06-01 | 2024-03-05 |
| ACEI or ARB and COVID-19 Severity and Mortality in US Veterans ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID | Completed | University of Utah | 22213 | 2020-01-19 | 2021-04-28 | |
| A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension reserpine, stellate ganglion block, lidocaine - Pulmonary Artery Hypertension | Phase 1 | Withdrawn | Mayo Clinic | 2016-07-01 | 2019-05-22 | |
| Mechanisms of Refractory Hypertension (Reserpine) Reserpine - Refractory Hypertension | Phase 2 | Completed | University of Alabama at Birmingham | 7 | 2015-07-23 | 2021-11-30 |
| A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1 Reserpine - Amphetamine-Related Disorders | Phase 1 | Unknown | National Institute on Drug Abuse (NIDA) | 30 | 2004-01-01 | 2017-01-11 |
| Reserpine for the Treatment of Cocaine Dependence - 1 Reserpine - Cocaine-Related Disorders, Substance-Related Disorders | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 140 | 2001-07-01 | 2017-01-12 |
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) Anti-hyperglycemic Agents, Anti-hypertensive Agents, Blinded fenofibrate or placebo plus simvastatin - Atherosclerosis, Cardiovascular Diseases | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 10251 | 1999-09-01 | 2016-11-22 |
| Systolic Hypertension in the Elderly Program (SHEP) chlorthalidone, atenolol, reserpine - Cardiovascular Diseases, Cerebrovascular Disorders | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1984-06-01 | 2016-04-15 | |
| Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study) chlorthalidone, reserpine, hydralazine - Cardiovascular Diseases, Heart Diseases | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1980-09-01 | 2013-11-26 |
Hypertension (5) · Cardiovascular Diseases (3) · Heart Diseases (2) · Amphetamine-Related Disorders (1) · Atherosclerosis (1) · Brain Injuries, Traumatic (1) · Cerebrovascular Disorders (1) · Cocaine-Related Disorders (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Familial Primary Pulmonary Hypertension (1) · Hypercholesterolemia (1) · Substance-Related Disorders (1) · Vascular Diseases (1)
National Heart, Lung, and Blood Institute (NHLBI) (3) · National Institute on Drug Abuse (NIDA) (2) · Mayo Clinic (1) · University of Alabama at Birmingham (1) · University of Utah (1) · Zeng Changhao (1)
United States (6) · Canada (1) · China (1)
Adam P Bress, PharmD, MS (1) · C. Hawkins (1) · David A Calhoun, MD (1) · Denise Simons-Morton, MD, PhD (1) · Eugene Somoza, M.D., Ph.D. (1) · H. Perry (1) · Harold Schnaper (1) · James Schoenberger (1) · Joseph Blackshear, MD (1) · Merwyn Greenlick (1) · Nieto Luis, Doctor (1) · Reese Jones, M.D. (1) · Robert Byington, PhD (1) · Robert McDonald (1) · William Friedewald, MD (1)
PMID 41903707, PMID 18539917, PMID 19898642, PMID 20061358, PMID 20061360, PMID 20215456, PMID 20228401, PMID 20228404, PMID 20427682, PMID 20571135, PMID 20587587, PMID 20594588, PMID 21366473, PMID 21663644, PMID 21958949, PMID 22019270, PMID 22049171, PMID 22179956, PMID 22374637, PMID 22432114, PMID 22450889, PMID 22515638, PMID 22619083, PMID 22646230, PMID 22723577, PMID 23033246, PMID 23238658, PMID 23412077, PMID 23990163, PMID 24170759, PMID 24296848, PMID 24493100, PMID 24595629, PMID 24779562, PMID 25088437, PMID 25127725, PMID 25159234, PMID 25172198, PMID 25193529, PMID 25229335, PMID 25267796, PMID 25652389, PMID 25666468, PMID 25887355, PMID 25938124, PMID 25969833, PMID 26261902, PMID 26459421, PMID 26464212, PMID 26476086
N01HC95178 (1), N01HC95179 (1), N01HC95180 (1), N01HC95181 (1), N01HC95182 (1), N01HC95183 (1), N01HC95184 (1)